Ellington Management Group’s AstraZeneca AZN Stock Holding History

Ellington Management Group’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-16,150	Closed	-$1.44M	–	73
2020 Q1	$1.44M	Buy	16,150 +13,500	+509%	+$1.27M	0.34%	54
2019 Q4	$264K	Buy	+2,650	New	+$249K	0.06%	350
2018 Q3	–	Sell	-8,750	Closed	-$614K	–	507
2018 Q2	$614K	Sell	8,750 -1,950	-18%	-$140K	0.04%	143
2018 Q1	$748K	Buy	+10,700	New	+$741K	0.05%	291
2017 Q4	–	Sell	-8,450	Closed	-$573K	–	592
2017 Q3	$573K	Buy	+8,450	New	+$534K	0.1%	174
2017 Q1	–	Sell	-17,100	Closed	-$934K	–	685
2016 Q4	$934K	Buy	+17,100	New	+$971K	0.14%	80

Other funds holding AZN

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Jennison Associates New York $167B AUM 44.17% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

GQG Partners Ft. Lauderdale, Florida $53.8B AUM 19.23% 1-Year Est. Return

Ellington Management Group's AZN Position: Q2 2020 in Review

Ellington Management Group sold out of AstraZeneca (AZN) in Q2 2020, closing a stake of 16,150 shares — an estimated $1.44M sold.

Ellington Management Group first reported a position in AZN in Q4 2016 and held it in 6 quarters. The position peaked at $1.44M in Q1 2020. 669 funds tracked by Wall St. Rank hold AZN as of Q2 2020.

Ellington Management Group reported no remaining AstraZeneca position as of Q2 2020 after selling out during the quarter.
Ellington Management Group sold 16,150 AstraZeneca shares in Q2 2020, an estimated $1.44M.
Ellington Management Group first reported a position in AstraZeneca in Q4 2016 and held it in 6 quarters.
Ellington Management Group's AstraZeneca position peaked at $1.44M in Q1 2020.
669 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2020.

Based on Ellington Management Group's 13F filing for Q2 2020, filed 17 Aug 2020.